Literature DB >> 30717971

MiR-155 expressed in bone marrow-derived lymphocytes promoted lipopolysaccharide-induced acute lung injury through Ang-2-Tie-2 pathway.

Yumeng Yan1, Yan Lou2, Juan Kong3.   

Abstract

Acute lung injury (ALI) is a type of diffuse lung inflammation with a high mortality rate. Studies show that miR-155 plays an important role in inflammation. Here, we investigated the role of miR-155 in lipopolysaccharide (LPS)-induced ALI. The mice with bone marrow transplantation between MiR-155 knockout and wild-type were used as animal models of LPS-induced sepsis. In response to LPS injection, ALI was less severe in miR-155 knockout mice than in wild-type mice, and mainly manifested as reduced pulmonary vascular leakage, pulmonary edema, and neutrophil infiltration. The expression levels of Ang-2 and apoptosis-associated caspases-3 and -9, as well as myosin light chain (MLC) phosphorylation in the lungs were also decreased. A bone marrow transplantation experiment showed that miR-155 expressed in bone marrow-derived lymphocytes rather than lung parenchymal lymphocytes promoted inflammation. Findings suggest that miR-155 expressed in bone marrow-derived lymphocytes promoted LPS-induced ALI through the modulation of the Ang-2-Tie-2 pathway.
Copyright © 2019. Published by Elsevier Inc.

Entities:  

Keywords:  Acute lung injury; Ang2-Tie2 pathway; Bone marrow transplantation; miR-155

Mesh:

Substances:

Year:  2019        PMID: 30717971     DOI: 10.1016/j.bbrc.2019.01.079

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Propofol Regulates the TLR4/NF-κB Pathway Through miRNA-155 to Protect Colorectal Cancer Intestinal Barrier.

Authors:  Yuhua Gao; Tao Han; Cailing Han; Hua Sun; Xiaoxia Yang; Dongmei Zhang; Xinli Ni
Journal:  Inflammation       Date:  2021-06-03       Impact factor: 4.092

2.  MicroRNA‑129 plays a protective role in sepsis‑induced acute lung injury through the suppression of pulmonary inflammation via the modulation of the TAK1/NF‑κB pathway.

Authors:  Wenjian Yao; Lei Xu; Xiangbo Jia; Saisai Li; Li Wei
Journal:  Int J Mol Med       Date:  2021-06-03       Impact factor: 4.101

3.  Diagnostic value of miR-155 for acute lung injury/acute respiratory distress syndrome in patients with sepsis.

Authors:  Zhou-Feng Wang; Yu-Min Yang; Heng Fan
Journal:  J Int Med Res       Date:  2020-07       Impact factor: 1.671

Review 4.  MicroRNA-155: Regulation of Immune Cells in Sepsis.

Authors:  Ming Chen; Fuquan Wang; Haifa Xia; Shanglong Yao
Journal:  Mediators Inflamm       Date:  2021-01-08       Impact factor: 4.711

5.  MiR-155/GSK-3β mediates anti-inflammatory effect of Chikusetsusaponin IVa by inhibiting NF-κB signaling pathway in LPS-induced RAW264.7 cell.

Authors:  Yi Xin; Qin Yuan; Chaoqi Liu; Changcheng Zhang; Ding Yuan
Journal:  Sci Rep       Date:  2020-10-27       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.